Access

You are not currently logged in.

Access JSTOR through your library or other institution:

login

Log in through your institution.

Impact of Measles in France

Michel Rey, Josette Celers, Yves Mouton and Robert Netter
Reviews of Infectious Diseases
Vol. 5, No. 3, 1982 International Symposium on Measles Immunization (May - Jun., 1983), pp. 433-438
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4453052
Page Count: 6
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Impact of Measles in France
Preview not available

Abstract

Although measles vaccine has been licensed since 1968, immunization against measles has not met with much success in France, partly because the disease is no longer feared. The level of vaccination coverage appears to be <20%. Indeed, the present epidemiologic situation is similar to the natural situation in a developed country. A multicenter, retrospective hospital survey revealed that 1,157 patients with measles were hospitalized during a 30-month period in five areas (total population, 4.2 million). Analysis of the preliminary results of this survey and of available national data showed an incidence of 5.6-7.5 cases per 1,000 population; a hospitalization rate of one per 10,000; a death rate of 0.56 per 1 million; and a disability rate of 0.48 per 1 million. Encephalitis (the definition of which should be reappraised) occurred once in 2,850 cases, and subacute sclerosing panencephalitis was not rare (incidence, one case per 2.6 million people). The problem posed by measles is sufficiently grave to justify a national campaign urging the widespread vaccination of children.

Page Thumbnails

  • Thumbnail: Page 
433
    433
  • Thumbnail: Page 
434
    434
  • Thumbnail: Page 
435
    435
  • Thumbnail: Page 
436
    436
  • Thumbnail: Page 
437
    437
  • Thumbnail: Page 
438
    438